We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tabletop Ultracentrifuge Suitable for Biosafety Hood Use

By LabMedica International staff writers
Posted on 25 Jun 2012
Biotech and other life science research laboratories now have available a new tabletop ultracentrifuge that provides the separation capabilities of free standing centrifuges while being compact enough to fit within a standard biosafety hood.

Beckman Coulter Life Sciences (Brea, CA, USA) recently introduced the Optima MAX-TL tabletop ultracentrifuge. More...
This instrument is fully compatible with Beckman Coulter’s TL labware and fixed-angle, swinging bucket, and unique near-vertical tube (NVT) rotors. Operators have the option of inputting multiple programs of up to five steps each using an easily navigated, full-color LCD touch-screen accessible in nine languages: English, Spanish, German, Japanese, French, Italian, Russian, Portuguese and Chinese (simplified). Context-sensitive onscreen help is available in multiple native languages.

The Optima MAX-TL is capable of reaching a maximum speed of 120,000 rpm and maximum rcf [relative centrifugal force] of 657,000 x g. Temperatures in the centrifuge can be set from 0 to 40 degrees Celsius in one degree Celsius increments. The instrument operates in ambient temperatures from 15 to 35 degrees Celsius.

With its compact size allowing the instrument to be used inside biosafety or laminar flow hoods, the Optima MAX-TL should prove to be an excellent tool for applications such as separation of subcellular particles, separation of viruses and viral particles, rate-zonal separation of proteins in sucrose gradient, separation of lipoproteins, pelleting of RNA through a cesium chloride gradient, isopycnic separation of plasmid DNA, and others.

“The Optima MAX-TL tabletop is an instrument for those working with smaller sample sizes and fills out our best-in-class line of ultracentrifuges,” said Patrick O’Donnell, senior global manager of marketing at Beckman Coulter. “The unit’s features and user-friendly qualities will make it of great service to researchers.”

Related Links:
Beckman Coulter Life Sciences



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.